Umecrine Cognition

The submission represents 'Umecrine Cognition', a legitimate clinical-stage biopharmaceutical company developing treatments for hepatic encephalopathy. However, the submission itself is of extremely low quality and contains blatant inaccuracies. The claim that 'most people have used my product' is factually false for a specialized biotech firm, and the launch date (1970) appears to be a default Unix timestamp error. While the underlying technology has high real-world utility and innovation, the 'Proof of Usefulness' is severely penalized by the lack of verifiable traction data in the submission and the hyperbolic, unreliable claims provided.